Quantcast
Last updated on April 23, 2014 at 21:24 EDT

Latest Queen's University Stories

2013-09-20 11:23:28

Preeclampsia (PE) is a high blood pressure disorder that occurs during pregnancy and which can cause illness or death for the fetus and mother-to-be. There is currently no cure except to deliver the fetus, perhaps prematurely, or remove the placenta, a key organ that binds the pair. Women who smoke during pregnancy have been found to have as much as a 33 percent lower rate of preeclampsia for reasons that are unclear. A new study using an animal model to mimic key effects of PE in humans, and...

2013-06-10 12:24:49

TORONTO, June 10, 2013 /CNW Telbec/ - Bell and Queen's University today announced the launch of the Annual Bell Lecture on Mental Health and Anti-Stigma, an initiative aimed at raising awareness of mental health and reducing the stigma associated with mental illness. The inaugural lecture, entitled Breaking the Silence, will be held on June 25 at the TIFF Bell Lightbox in Toronto and will feature leading mental health researcher Dr. Heather Stuart and award-winning author James...

2013-05-30 23:02:21

The Society for Translational Oncology (STO) is pleased to announce that Professor Patrick G. Johnston, M.D., Ph.D, Dean of the School of Medicine, Dentistry & Biomedical Sciences, Queen´s University Belfast, Northern Ireland, has been named recipient of the 2013 Bob Pinedo Cancer Care Prize. Durham, NC (PRWEB) May 30, 2013 The Society for Translational Oncology (STO) is pleased to announce that Professor Patrick G. Johnston, M.D., Ph.D, Dean of the School of Medicine, Dentistry...

2013-01-25 10:25:58

The first ever review of abuse cases related to child death or serious injury in Northern Ireland will be launched at Queen's University today (24 January 2013). The review, Translating Learning into Action, was commissioned by the Department of Health, Social Services and Public Safety (DHSSPS) and was carried out by researchers at Queen's University and the NSPCC. The Case Management Review (CMR) report — the first to be produced in Northern Ireland - analyzed 24 case reviews...

2013-01-07 08:34:55

CAMBRIDGE, England and KINGSTON, Ontario, January 7, 2013 /PRNewswire/ -- Intel(R), Plastic Logic and Queen's University work together to revolutionize tablet computing Watch out tablet lovers - a flexible paper computer developed at Queen's University in collaboration with Plastic Logic and Intel Labs will revolutionize the way people work with tablets and computers. The PaperTab tablet looks and feels just like a sheet...

2012-06-21 02:26:13

CALGARY, June 21, 2012 /PRNewswire/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC) (NASDAQ:ONCY) today announced that it has entered into an agreement whereby the NCIC Clinical Trials Group (NCIC CTG) at Queen's University in Kingston, Ontario, will sponsor and conduct a randomized Phase II study of REOLYSIN(®) in patients with advanced or metastatic breast cancer. "We are excited to announce our fourth randomized study with the NCIC CTG," said Dr. Brad Thompson, President...

2012-06-05 02:27:45

--Company to Host Conference Call to Discuss Randomized Phase II Program-- CALGARY, June 5, 2012 /PRNewswire/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC) (NASDAQ:ONCY) announced today that it has entered into an agreement whereby the NCIC Clinical Trials Group (CTG) at Queen's University in Kingston, Ontario, will sponsor and conduct a randomized Phase II study of REOLYSIN(®) in patients with advanced or metastatic non-small cell lung cancer ("NSCLC"). "This agreement...

2012-05-03 02:31:45

CALGARY, May 3, 2012 /PRNewswire/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that it has entered into an agreement whereby the NCIC Clinical Trials Group (CTG) at Queen's University in Kingston, Ontario, will sponsor and conduct a randomized Phase II study of REOLYSIN(®) in patients with advanced or metastatic colorectal cancer. "We are pleased to be conducting a second randomized study with the NCIC CTG," said Dr. Brad Thompson, President and...

2012-04-30 19:52:30

A synthetic mixture of intestinal bacteria could one day replace stool transplants as a treatment for Clostridium difficile (C. difficile) A synthetic mixture of intestinal bacteria could one day replace stool transplants as a treatment for Clostridium difficile (C. difficile). C. difficile is a toxin-producing bacteria that can overpopulate the colon when antibiotics eradicate other, naturally protective bacteria living there. "A synthetic stool transplant has a lot of potential...

2012-04-19 12:33:38

New research from Queen's University Belfast, published today in the journal Age and Ageing, has investigated why women are 40 per cent more likely to be admitted in to a care home than men. The study found women were often married to older partners who cannot provide care for them due to their age-related frailty. The study, entitled 'Gender differences in care home admission risk: Partner's age explains the higher risk for women', used data from the Northern Ireland Longitudinal Study...